Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:DiaSorin
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:focusesOn |
molecular diagnostics
immunoassays |
| gptkbp:foundedYear |
1995
|
| gptkbp:founder |
gptkb:Patrick_J._Balthrop
|
| gptkbp:headquartersLocation |
gptkb:Austin,_Texas,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Luminex
|
| gptkbp:industry |
gptkb:biotechnology
medical diagnostics |
| gptkbp:notableProduct |
gptkb:ARIES_System
gptkb:MAGPIX_System gptkb:VERIGENE_System gptkb:xMAP_Technology |
| gptkbp:numberOfEmployees |
~1200 (as of 2021)
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:specializesIn |
biological testing
multiplexing technology |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:LMNX
|
| gptkbp:website |
https://www.luminexcorp.com/
|
| gptkbp:bfsParent |
gptkb:L1000_assay
|
| gptkbp:bfsLayer |
5
|